Vanguard Portfolio Management’s SELLAS Life Sciences SLS Stock Holding History
Bought
Maintained
Sold
Other funds holding SLS
DI
Vanguard Portfolio Management's SLS Position: Q3 2026 in Review
Vanguard Portfolio Management increased its SELLAS Life Sciences (SLS) stake by 6.3% in Q3 2026, buying an estimated $1.71M and bringing the position to 2,297,581 shares worth $28.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1853.
Vanguard Portfolio Management first reported a position in SLS in Q1 2026 and has held it in 3 quarters since. The position peaked at $31.9M in Q2 2026. 168 funds tracked by Wall St. Rank hold SLS as of Q3 2026.
- Vanguard Portfolio Management held 2,297,581 shares of SELLAS Life Sciences worth $28.3M as of Q3 2026.
- Vanguard Portfolio Management bought 136,482 SELLAS Life Sciences shares in Q3 2026, an estimated $1.71M.
- SELLAS Life Sciences made up ﹤0.01% of Vanguard Portfolio Management's portfolio in Q3 2026, its #1853 holding.
- Vanguard Portfolio Management first reported a position in SELLAS Life Sciences in Q1 2026 and has held it in 3 quarters since.
- Vanguard Portfolio Management's SELLAS Life Sciences position peaked at $31.9M in Q2 2026.
- 168 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q3 2026.
Based on Vanguard Portfolio Management's 13F filing for Q3 2026, filed 13 Nov 2026.